Literature DB >> 10913153

Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling.

V W Ding1, R H Chen, F McCormick.   

Abstract

Glycogen synthase kinase 3beta (GSK3beta) is a key component in many biological processes including insulin and Wnt signaling. Since the activation of each signaling pathway results in a decrease in GSK3beta activity, we examined the specificity of their downstream effects in the same cell type. Insulin induces an increased activity of glycogen synthase but has no influence on the protein level of beta-catenin. In contrast, Wnt increases the cytosolic pool of beta-catenin but not glycogen synthase activity. We found that, unlike insulin, neither the phosphorylation status of the serine9 residue of GSK3beta nor the activity of protein kinase B is regulated by Wnt. Although the decrease in GSK3beta activity is required, GSK3beta may not be the limiting component for Wnt signaling in the cells that we examined. Our results suggest that the axin-conductin complexed GSK3beta may be dedicated to Wnt rather than insulin signaling. Insulin and Wnt pathways regulate GSK3beta through different mechanisms, and therefore lead to distinct downstream events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913153     DOI: 10.1074/jbc.M005342200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  160 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Can a two-faced kinase be exploited for osteosarcoma?

Authors:  James R Woodgett
Journal:  J Natl Cancer Inst       Date:  2012-04-24       Impact factor: 13.506

Review 3.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

4.  Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.

Authors:  Ram Sudheer Adluri; Mahesh Thirunavukkarasu; Lijun Zhan; Yuzo Akita; Samson Mathews Samuel; Hajime Otani; Ye-Shih Ho; Gautam Maulik; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2010-11-11       Impact factor: 5.000

5.  Crosstalk between SOXB1 proteins and WNT/β-catenin signaling in NT2/D1 cells.

Authors:  Marija Mojsin; Vladanka Topalovic; Jelena Marjanovic Vicentic; Marija Schwirtlich; Danijela Stanisavljevic; Danijela Drakulic; Milena Stevanovic
Journal:  Histochem Cell Biol       Date:  2015-08-04       Impact factor: 4.304

6.  The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions.

Authors:  Maire Gavagan; Erin Fagnan; Elizabeth B Speltz; Jesse G Zalatan
Journal:  Cell Syst       Date:  2020-06-17       Impact factor: 10.304

7.  C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Authors:  Ryo Otsuka; Nagakatsu Harada; Shouhei Aoki; Kanna Shirai; Kazuchika Nishitsuji; Ayane Nozaki; Adzumi Hatakeyama; Masayuki Shono; Noriko Mizusawa; Katsuhiko Yoshimoto; Yutaka Nakaya; Hiroshi Kitahata; Hiroshi Sakaue
Journal:  Cell Stress Chaperones       Date:  2015-08-30       Impact factor: 3.667

Review 8.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

9.  Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action.

Authors:  Atefeh Rabiee; Marcus Krüger; Jacob Ardenkjær-Larsen; C Ronald Kahn; Brice Emanuelli
Journal:  Cell Signal       Date:  2018-03-14       Impact factor: 4.315

Review 10.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.